Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Prostate Cancer”

841 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 841 results

Testing effectiveness (Phase 2)Ended earlyNCT02648919
What this trial is testing

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Hawaii 6
Not applicableUnknownNCT05430737
What this trial is testing

A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer

Who this might be right for
Prostate CancerStereotactic Body RadiotherapyHigh-risk+2 more
West China Hospital 60
Very early researchStudy completedNCT04301414
What this trial is testing

Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Columbia University 26
Early research (Phase 1)Study completedNCT02064036
What this trial is testing

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University of California, Davis 17
Testing effectiveness (Phase 2)Study completedNCT01946165
What this trial is testing

Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 69
Large-scale testing (Phase 3)UnknownNCT00003734
What this trial is testing

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
St. Luke's Hospital, Ireland 276
Not applicableLooking for participantsNCT04550845
What this trial is testing

Understanding of Genetics by Men at Risk for Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 90
Not applicableWithdrawnNCT00963300
What this trial is testing

MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center
Not applicableNot Yet RecruitingNCT06945172
What this trial is testing

Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU

Who this might be right for
Prostate Cancer
GCS Ramsay Santé pour l'Enseignement et la Recherche 102
Not applicableStudy completedNCT02895230
What this trial is testing

Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study

Who this might be right for
Prostate CancerAndrogen-deprivation Therapy
Rennes University Hospital 38,690
Not applicableLooking for participantsNCT06027892
What this trial is testing

Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer

Who this might be right for
PROSTATE CANCER
Rabin Medical Center 562
Testing effectiveness (Phase 2)Study completedNCT01620515
What this trial is testing

Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer

Who this might be right for
Prostate Cancer
Nymox Corporation 141
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)WithdrawnNCT03035357
What this trial is testing

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Who this might be right for
Malignant Neoplasms of Male Genital OrgansProstate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00924807
What this trial is testing

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Medical Center 4
Not applicableStudy completedNCT02618161
What this trial is testing

Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment

Who this might be right for
Prostate Cancer
Mid and South Essex NHS Foundation Trust 100
Post-approval studies (Phase 4)Active Not RecruitingNCT06627530
What this trial is testing

COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer

Who this might be right for
Prostate Cancer
Brazilian Clinical Research Institute 144
Very early researchLooking for participantsNCT06888102
What this trial is testing

A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer

Who this might be right for
High-risk Prostate Cancer
Edwin Posadas, MD 20
Testing effectiveness (Phase 2)Study completedNCT01250717
What this trial is testing

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 28
Not applicableWithdrawnNCT00621413
What this trial is testing

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
IsoRay Medical, Inc.
Load More Results